CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 16 10:24 PM | James N WilsonDirector | Sale | 10,000 | $114.81 | $1.1M | 1,054,543(I) | View → |
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 8,333 | $116.10 | $967.4K | 3,946(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 9,190 | $116.13 | $1.1M | 5,683(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 810 | $115.40 | $93.5K | 5,683(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 24,587 | $116.28 | $2.9M | 9,938(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 413 | $115.54 | $47.7K | 9,938(D) | View → |
| Oct 1, 2026 | Oct 1 3:09 PM | Lyon Joseph Douglas | Proposed Sale | 10,000 | $115.23 | $1.2M | — | View → |
| Sep 16, 2026 | Sep 18 11:53 PM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 296 | $100.82 | $29.8K | 3,946(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 10,000 | $113.49 | $1.1M | 5,683(D) | View → |
| Sep 15, 2026 | Sep 16 8:30 PM | James N WilsonDirector | Sale | 10,000 | $110.69 | $1.1M | 1,064,543(I) | View → |
| Sep 15, 2026 | Sep 15 2:23 PM | WILSON JAMES N | Proposed Sale | 30,000 | $111.48 | $3.3M | — | View → |
| Sep 14, 2026 | Sep 14 5:58 PM | Lyon Joseph Douglas | Proposed Sale | 10,000 | $113.44 | $1.1M | — | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 25,000 | $114.43 | $2.9M | 9,755(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 58,333 | $110.76 | $6.5M | 4,242(D) | View → |
| Sep 2, 2026 | Sep 2 8:08 PM | Vieira Roberto Wandenkolk | Proposed Sale | 75,295 | $110.76 | $8.3M | — | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Sale | 26,685 | $122.55 | $3.3M | 0(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 30,955 | $125.58 | $3.9M | 9,755(D) | View → |
| Aug 26, 2026 | Aug 26 8:14 PM | KIMBERLY PARK | Proposed Sale | 26,685 | $122.55 | $3.3M | — | View → |
| Aug 25, 2026 | Aug 25 9:24 PM | Maduck Sean | Proposed Sale | 175,000 | $125.58 | $22.0M | — | View → |
| Aug 18, 2026 | Aug 20 8:30 PM | David L MahoneyDirector | Sale | 103,606 | $118.25 | $12.3M | 1,133,539(I) | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 8,333 | $21.63 | 133,334(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 9,190 | $19.26 | 44,167(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 810 | $13.56 | 3,357(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 24,587 | $8.27 | 41,986(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 413 | $8.27 | 66,573(D) | View → |
| Oct 1, 2026 | Oct 5 11:44 PM | Justin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 100,000 | $114.03 | 100,000(D) | View → |
| Sep 17, 2026 | Sep 18 11:47 PM | Gary Charles RobbChief Business Officer | Option Exercise | 17,493 | $8.27 | 182,507(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 10,000 | $13.56 | 4,167(D) | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 25,000 | $8.27 | 66,986(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 58,333 | $21.63 | 141,667(D) | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Option Exercise | 30,000 | $13.49 | 30,000(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 30,955 | $11.35 | 169,045(D) | View → |
| Aug 14, 2026 | Aug 18 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 3,664 | $8.27 | 91,986(D) | View → |
| Aug 10, 2026 | Aug 12 8:27 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 1,031 | $8.27 | 95,650(D) | View → |
| Aug 10, 2026 | Aug 12 8:26 PM | William GuyerChief Development Officer | Option Exercise | 16,300 | $21.65 | 110,000(D) | View → |
| Aug 4, 2026 | Aug 6 10:44 PM | William GuyerChief Development Officer | Option Exercise | 3,700 | $21.65 | 126,300(D) | View → |
| Aug 3, 2026 | Aug 5 9:51 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 20,305 | $8.27 | 96,681(D) | View → |
| Jul 30, 2026 | Aug 3 8:30 PM | Atabak MokariChief Financial Officer | Option Exercise | 80,000 | $23.06 | 95,833(D) | View → |
| Jul 15, 2026 | Jul 17 10:31 PM | Atabak MokariChief Financial Officer | Option Exercise | 40,000 | $23.06 | 175,833(D) | View → |
| Jul 7, 2026 | Jul 8 11:54 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 130,000(D) | View → |
Page 1 of 3
Next →